0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinical Sciences |

Retinal Venular Diameter as an Early Indicator of Progression to Proliferative Diabetic Retinopathy With and Without High-Risk Characteristics in African Americans With Type 1 Diabetes Mellitus FREE

Monique S. Roy, MD; Ronald Klein, MD; Malvin N. Janal, PhD
[+] Author Affiliations

Author Affiliation: Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry, New Jersey Medical School, Newark (Dr Roy); Department of Ophthalmology, University of Wisconsin, Madison (Dr Klein); and Department of Epidemiology and Health Promotion, NYU College of Dentistry, New York, New York (Dr Janal).


Arch Ophthalmol. 2011;129(1):8-15. doi:10.1001/archophthalmol.2010.340.
Text Size: A A A
Published online

Objective  To examine the relationship between retinal arteriolar and venular diameter and the 6-year progression of diabetic retinopathy (DR) in African Americans with type 1 insulin-dependent diabetes mellitus.

Methods  Included were 468 African Americans with type 1 diabetes mellitus who participated in the New Jersey 725 and who had undergone a 6-year follow-up examination. Seven standard field retinal photographs were obtained at both examinations. Computer-assisted grading, from digitized images of field 1 of baseline retinal photographs, was accomplished to determine the average diameter of retinal arterioles (central retinal arteriolar equivalent [CRAE]) and venules (central retinal venular equivalent [CRVE]). Retinal vessel diameter was examined in relation to the 6-year incidence and/or progression of DR.

Results  For right and left eyes, mean (SD) CRAE was 168.8 (16.0) μm and mean CRVE was 254.2 (25.2) μm. Both CRAE and CRVE were correlated between eyes (P < .001). Multivariate analysis with generalized estimating equations showed that larger CRVE in either the right or left eye was significantly associated with 6-year progression to either proliferative DR (PDR) or PDR with high-risk characteristics after adjusting for baseline clinical risk factors. Notably, a significant association between baseline CRVE and progression to PDR was present for eyes with no to moderate nonproliferative DR and also between baseline CRVE and progression to PDR with high-risk characteristics for eyes with no or nonproliferative DR.

Conclusion  Larger retinal venular diameter is an independent and early indicator of progression to either PDR or PDR with high-risk characteristics in African Americans with type 1 diabetes mellitus.

Dilation of the retinal venules is one of the clinically and pathologically noted retinal changes associated with diabetic retinopathy (DR).15 With the recent capability of computerized measurement of retinal vessel diameter from digitized retinal photographs, it is now possible to quantitatively evaluate retinal vessel diameter.68 With the use of this method in persons with type 1 or type 2 diabetes mellitus (DM), variation in the retinal vessel diameter has been shown to be significantly associated with various systemic and ocular end points, including DR severity.913 However, it is unclear from these cross-sectional studies whether alterations in retinal vessel diameters reflect only the severity of DR or might be used to predict DR progression.

There have been relatively few prospective studies of retinal vessel caliber changes in persons with type 1 DM.1416 In white patients with early-onset DM, larger venular diameters were predictors of the 4-year progression of DR and progression to proliferative DR (PDR), whereas larger retinal arteriolar diameters were predictors of 4-year progression of DR.14 In 2 other prospective studies of young patients with type 1 diabetes, larger retinal arteriolar diameters were also significantly associated with the incidence of DR.15,16

We previously assembled, examined, and subsequently reexamined (6 years later) a large group of African Americans with type 1 DM (the New Jersey 725).1719 At both visits, 7 standard retinal photographic fields were obtained and graded in a masked fashion by the Fundus Photograph Reading Center in Madison, Wisconsin. Detailed clinical information, including sociodemographic and diabetic complications, was obtained, thus providing a unique opportunity to examine whether retinal vessel diameter is a predictor of 6-year progression of DR in this high-risk population.

We hypothesized that larger retinal arteriolar and larger retinal venular diameters, as measured on retinal photographs of field 1 obtained at baseline examination, would predict progression (6-year) of DR in African Americans with type 1 DM.

STUDY POPULATION

The original cohort consisted of 725 African Americans with type 1 DM who participated in the New Jersey 725 study between 1993 and 1998.17 Patients diagnosed as having DM and treated with insulin before 30 years of age, and currently taking insulin, were identified from a random review of 13 615 medical records. Excluded were patients with type 2 DM, those diagnosed after age 30 years, and patients with maturity-onset diabetes of youth.20,21 Of the 875 eligible patients, 725 participated in the baseline examination.17,18

Of the original cohort of 725 patients, 508 (70.1%) participated in the 6-year follow-up examination, 44 (6.1%) could not be located, 34 (4.7%) refused examination, and 139 (19.2%) had died in the 6-year interval.19 At follow-up, 25 of the 508 participants (4.9%) were no longer receiving insulin and had not received a pancreas transplant. Because these patients may not be truly insulin dependent, they were excluded, as were patients with Buerger disease (n = 1) or systemic lupus (n = 3), leaving 479 patients (94.3%) eligible for analysis. Of those eligible, this report concerns the 468 (97.7%) who had gradable retinal photographs in at least 1 eye at the baseline examination. The mean (SD) time of follow-up was 6.1 (0.5) years, and median duration of follow-up, 5.96 years.

PROCEDURES

Patients were examined in the Eye Clinic at University Hospital in Newark, New Jersey. On arrival, informed written consent was obtained. Patients underwent a complete eye examination including (1) best-corrected visual acuity using the Early Treatment of Diabetic Retinopathy Study (ETDRS) protocol, (2) measurement of intraocular pressure by applanation, (3) dilated retinal examination, and (4) 7 standard stereoscopic Diabetic Retinopathy Study retinal photographs.22 Also obtained were height and weight. Blood pressure was measured twice in the sitting and standing positions with a random-zero sphygmomanometer according to the Hypertension Detection and Follow-up Program protocol.23 The average of the 2 measurements in each position was used. A structured clinical interview included detailed medical and ophthalmologic histories, as well as sociodemographic factors and lifestyle variables (ie, self-reported measures of cigarette smoking, alcohol consumption, and illicit drug abuse).

Venous blood was drawn for measurement of total glycosylated hemoglobin by means of high-performance liquid chromatography (Bio-Rad; Labcorp Laboratory, Hercules, California) and high- and low-density lipoprotein cholesterol and total cholesterol by means of an enzymatic assay and separation spectrophotometry (Genzyme Diagnostics, Cambridge, Massachusetts). The normal range for total glycosylated hemoglobin is 4.2% to 7.0%, and the intra-assay coefficient of variation, 0.38% to 1.47% (to convert to a proportion of total hemoglobin, multiply by 0.01). A 4-hour timed urine collection was obtained for measurement of albumin excretion rate and creatinuria by spectrophotometry (SmithKline Beecham Clinical Laboratory, Philadelphia, Pennsylvania). The institutional review board of the University of Medicine and Dentistry of New Jersey, New Jersey Medical School, approved the study.

DR GRADING

Color fundus photographs obtained at baseline and 6-year follow-up were graded for DR severity in a masked fashion by the Fundus Photograph Reading Center. The modified ETDRS Airlie House classification of DR was used4,5: level 10, no DR; levels 20 to 53, nonproliferative DR of increasing severity; levels 61 to 85, PDR of increasing severity; and level 71 or higher, PDR with high-risk characteristics (HRCs). For each eye, the maximum grade in any of the 7 standard photographic fields was used to define the retinopathy level according to the ETDRS severity scale.5

Macular edema (ME) was considered present if there was thickening of the retina with or without partial loss of retinal transparency within 1 disc diameter from the center of the macula and/or focal laser photocoagulation scars in the macular area and a documented history of ME.24 Clinically significant ME (CSME) was defined as thickening of the retina at or within 500 μm of the center of the macula; hard exudates at or within 500 μm of the center of the macula associated with thickening of the adjacent retina; an area of retinal thickening 1 disc diameter or larger, any part of which was within 1 disc diameter or less of the center of the macula; or focal laser photocoagulation scars of the macular area with a documented history of CSME.24

Eyes that could not be graded—because of opacities of the media, phthisis, or enucleation—were initially classified as “cannot grade.” For such persons, one of us (M.S.R.) reviewed all previous medical records. When a history of panretinal photocoagulation for PDR or pars plana vitrectomy for complications of PDR was documented by chart review, the DR level was scored as 85. Eyes that had an ETDRS grading less than 61 at the time of examination and had previously received laser photocoagulation for PDR, as documented by chart review, were classified as grade 61.

ASSESSMENT OF RETINAL VESSEL DIAMETERS

Retinal vessel diameters were measured (at the Ocular Epidemiology Reading Center in Madison) with a computer-assisted technique based on a standard protocol and a modification of formulas established for the Atherosclerosis Risk in Communities Study and described in detail elsewhere.68,25,26 Baseline retinal photographs of field 1 were converted to digital images by means of a high-resolution scanner with identical settings for all photographs. Using a computer software program (Retinal Analysis, Optimate, Madison), trained graders, masked to participant characteristics, measured the diameters of all arterioles and venules coursing through a specified area one-half to 1 disc diameter surrounding the optic disc. On average, 7 to 14 arterioles and an equal number of venules were measured for each eye. Individual arteriolar and venular measurements were combined into summary indexes that reflected the average retinal arteriolar (central retinal arteriolar equivalent [CRAE]) and venular (central retinal venular equivalent [CRVE]) diameter of an eye.25 The reliability of this retinal vessel grading approach has been shown to be high.27

DEFINITIONS

The 6-year incidence of any DR was calculated from all patients who at baseline had no DR (severity level 10/10) and who progressed to a severity level of 20/less than 20 or higher at follow-up. Two-step progression of DR was calculated for all patients who had no DR or nonproliferative DR at baseline (levels 10/10 through 53/53) and progressed at least 2 steps at follow-up (10/10 to 20/20 or higher, or 20/<20 to 35/<35 or higher, etc) as previously described by Klein et al.28 This scale has 13 steps (10/10, 20/<20, 20/20, 35/<35, 35/35, 43/<43, 43/43, 47/<47, 47/47, 53/<53, 53/53, 61+/<61, 61+/61+) with all levels of PDR grouped as 1 level. When 2-step progression was examined, patients with PDR at baseline (levels 61+/<61 or higher) were excluded. Progression to PDR was calculated for all patients who had no DR or nonproliferative DR at baseline (levels 10/10 through 53/53) and who progressed at follow-up to PDR (levels 61+/<61 or worse). Progression to PDR with HRCs was calculated for all patients who had no DR, nonproliferative DR, or PDR without HRCs at baseline (levels 10/10 through 65/65) and who progressed to PDR with HRCs (levels 71+/<71 or worse). Progression to vision-threatening DR was calculated for patients who had either no DR or nonproliferative DR at baseline (levels 10/10 through 53/53) or no ME and who progressed to either PDR (levels 61+/<61 or worse) or ME at follow-up. The 6-year incidence of ME (or CSME) was calculated for all patients who had no ME (or CSME) or had not received focal laser photocoagulation for ME (or CSME) in either eye at baseline and who either developed ME (or CSME) in at least 1 eye at follow-up or had received focal laser photocoagulation for ME in either eye since the baseline examination. When incidence of DR was calculated for individual eyes, similar definitions and data specific for either right or left eyes were used.

Patient's age was defined as the age at the time of baseline examination. Age at diagnosis of diabetes was the age at which the diagnosis of DM was first recorded by a physician in the patient's hospital record. Duration of DM was the time between age at diagnosis and age at baseline. Systemic hypertension was defined as present if, at baseline, either the systolic blood pressure was 140 mm Hg or higher or the diastolic blood pressure was 90 mm Hg or higher or if the patient was taking antihypertensive medication. Microproteinuria was defined as present if the baseline albumin excretion rate was 20 to 200 μg/min and overt proteinuria if the baseline albumin excretion rate was greater than 200 μg/min. Cardiovascular disease was considered present if, at baseline, (1) the patient reported having undergone foot or leg amputation for a circulatory problem (excluding amputation secondary to an infection) or having had a myocardial infarction or stroke, and (2) cardiovascular disease was confirmed with standardized criteria by review of medical records of all previous hospital admissions.

Socioeconomic status was classified according to the Goldthorpe and Hope social grading of occupations.29 Smoking was defined as “ever” or “never” a smoker.

STATISTICAL ANALYSIS

Statistical analyses were performed with SPSS version 17 (SPSS, Inc, Chicago, Illinois). Baseline characteristics of participants and nonparticipants were compared with unpaired, 2-tailed t test for continuous variables and χ2 statistics for categorical variables. Six-year incidence rates with 95% confidence intervals for any DR, 2-step progression of DR, progression to PDR with and without HRCs, progression to vision-threatening DR, and incidence of ME and/or CSME were calculated.

The association of CRAE and CRVE between left and right eyes was assessed with Pearson correlation coefficients. Measures of CRAE and CRVE of right and left eyes were averaged, and the relationship of the mean CRAE and CRVE with baseline clinical characteristics was examined by 1-way analysis of variance. Bivariate associations between CRAE and CRVE and incident outcomes were then assessed with χ2 tests. Generalized estimating equations analyses were used to test the association of baseline CRAE and CRVE with incident DR in right and left eyes, adjusting for both systemic and eye-specific predictors. Models were built in 5 successive steps with the following entered in each step: step 1, either CRAE or CRVE; step 2, baseline age, socioeconomic status, and sex; step 3, baseline body mass index, glycosylated hemoglobin level, and proteinuria; step 4, the retinal vessel diameter complementary to that used in step 1; and step 5, ocular perfusion pressure and refractive error. A second model was also built for the same incident outcomes substituting mean arterial blood pressure for proteinuria.

Baseline characteristics of patients are presented in Table 1. Compared with patients who were excluded, those who were included were significantly younger, had lower systolic blood pressure and mean arterial blood pressure, had higher glycosylated hemoglobin values, had higher high-density lipoprotein cholesterol levels, and were less likely to have hypertension, PDR, and/or overt proteinuria.

Table Graphic Jump LocationTable 1. Baseline Characteristics of African Americans With Type 1 Diabetes Mellitus
CRAE AND CRVE IN RIGHT AND LEFT EYES

Mean (SD) CRAE was 168.8 (16.0) μm for both eyes and 168.2 (16.3) μm and 169.9 (17.5) μm for right and left eyes, respectively. Mean CRVE was 254.2 (25.2) μm for both eyes and 254.3 (27.3) μm and 254.6 (27.7) μm for right and left eyes, respectively. Both CRAE and CRVE were significantly correlated between eyes (both r = 0.71, P < .001) and were well approximated by the normal distribution.

RELATIONSHIP BETWEEN MEAN CRAE AND CRVE AND BASELINE CHARACTERISTICS

Mean CRAE was inversely related to age, duration of diabetes, body mass index, mean arterial blood pressure and pulse pressure, severity of DR, ocular perfusion pressure, and myopic refractive error (Table 2). Smaller CRAE was also associated with the presence of hypertension and proteinuria.

Table Graphic Jump LocationTable 2. Relationship Between Mean CRAE and CRVE and Baseline Clinical Characteristics in African Americans With Type 1 Diabetes Mellitus

Mean CRVE was inversely related to pulse pressure, presence of hypertension, and myopic refractive error (Table 2). Larger CRVE was found in women than in men and in those with more severe DR. Patients who had received laser photocoagulation for PDR had smaller CRAE and CRVE.

RELATIONSHIP BETWEEN CRAE AND CRVE AND 6-YEAR PROGRESSION OF DR
Bivariate Analyses

Table 3 shows that larger CRVE was associated with a higher risk for 6-year progression to both PDR and PDR with HRCs, but neither CRAE nor CRVE was related to any other incident outcomes. Furthermore, there was a suggestion of interaction between baseline DR severity and CRVE. Table 3 shows that progression to PDR or to PDR with HRCs was significantly associated with increasing CRVE for eyes with lower levels of DR severity at baseline (ETDRS level <43 for progression to PDR [P = .03] and ETDRS level <61 for progression to PDR with HRCs [P = .01]). For eyes with DR severity higher than these at baseline, however, there was no association between CRVE and progression to PDR or PDR with HRCs.

Table Graphic Jump LocationTable 3. Relationship of CRAE and CRVE to 6-Year Incidence of DR: Univariate Analysis
Multivariate Generalized Estimating Equations Analyses

After adjustment for confounding risk factors including age, sex, socioeconomic status, body mass index, glycosylated hemoglobin value, proteinuria, CRAE, ocular perfusion pressure, and refractive error, increasing baseline CRVE in right and left eyes was associated with at least a tripling of the risk of progression to either PDR or PDR with HRCs (model 1, Table 4). In addition to CRVE, increasing baseline age and glycosylated hemoglobin levels, as well as the presence of proteinuria, were also found to be independently associated with an increased risk of progression to PDR with or without HRCs. When baseline proteinuria was replaced in the model with baseline mean arterial blood pressure, the risk of progression to PDR with or without HRCs was again associated with larger baseline CRVE, increasing age, glycosylated hemoglobin value, and hypertension, the last being significant only for those progressing to PDR (model 2, Table 4). These results were unchanged when generalized estimating equations analyses were repeated for eyes with lower levels of severity of DR at baseline (ETDRS level <43 for PDR and <61 for PDR with HRCs) (data not shown). Thus, the association between CRVE and progression of DR that was apparent at lower levels of DR in Table 3 held up to adjustment.

Table Graphic Jump LocationTable 4. Relationship of Baseline CRVE in Right and Left Eyes to 6-Year Progression to Either PDR or PDR With HRCs: Multivariate GEE Analyses

Results of the present study indicate that larger retinal venular diameters, as measured on baseline color retinal photographs by a computer-assisted technique, are indicators of 6-year progression to PDR with or without HRCs in African Americans with type 1 DM, independent of other risk factors for progression of the disease.

These results are consistent with those of a similar report for white patients with type 1 DM.14 For instance, in the Wisconsin Epidemiologic Study of Diabetic Retinopathy, Klein et al14 showed that larger retinal venular diameter, obtained with a computerized technique similar to that used in the present study, was significantly and independently associated with 4-year progression of DR and incidence of PDR. In that study, the relationship between CRVE and progression of DR was greater for patients with more severe DR at baseline.14 In contrast, data from our study suggest that larger CRVE is a more important indicator of progression to PDR with or without HRCs for eyes with less severe DR at baseline (no to moderate nonproliferative DR and no to severe nonproliferative DR, respectively). Thus, larger CRVE appears to be an early indicator of progression to PDR in African Americans with type 1 DM.

The relative dilation of the retinal veins seen in DR and other retinopathies associated with ischemia has been variously interpreted. Wider retinal venules may reflect metabolic changes associated with DM, such as increased lactic acidosis.30 Stefansson et al31 also suggested that retinal vessel diameters are influenced by retinal oxygenation and that the dilation of the retinal vasculature may indicate retinal hypoxia. In support of the latter idea is the finding that lower arteriolar oxygen saturation in the blood is associated with larger retinal venular diameters.32 Another possibility is that dilation of the retinal veins in DR may reflect inflammation, one of the pathogenic factors thought to be involved in the development and/or progression of DR.33,34 For instance, wider retinal vessel diameters have been found to be associated with higher levels of inflammatory biomarkers.3537 Wider retinal venules in persons with DM may also reflect endothelial dysfunction. In support of this theory is the fact that the vasodilatory response of the retinal vessels to flicker-light stimulation—which is mediated by nitric oxide—is reduced in persons with DM compared with that of nondiabetic controls and deteriorates further with increasing DR severity.38,39 This reduced flicker-induced vasodilation is independent of other risk factors for DM or DR, is more pronounced in patients with type 1 DM, and correlates with retinal vascular caliber measurements.39,40

As previously reported for other populations, there is a high correlation between eyes for both CRAE and CRVE.41 Also, myopia and higher ocular perfusion pressure are significantly associated with smaller retinal vessel diameters.10,41 However, in the present study, adjusting for refractive error or ocular perfusion pressure did not alter the results.

In our African American patients, panretinal laser photocoagulation is associated with smaller retinal vessel diameters, as previously reported.42 It has been suggested that laser photocoagulation scars allow more oxygen to reach the inner retina, resulting in retinal arteriolar constriction and reduction in retinal blood flow.31 This reduction, in turn, may lead to regression of the endothelial cell proliferation and retinal vascular leakage present in DR consistent with the beneficial effects of laser photocoagulation.31

Unlike other studies, we found no association between CRAE and any of the incident DR outcomes after adjusting for confounding risk factors.1416,43 This lack of association may have been due to selective survival in our cohort because retinal arteriolar narrowing is associated with mortality in persons with DM.44,45 It is noteworthy that wider retinal arteriolar diameters have been shown to be significantly and independently associated with incidence of DR in persons with type 1 DM1416,43 and narrower arteriolar diameters with incidence of type 2 DM.4648 Thus, there is increasing evidence from various studies that changes in retinal arteriolar and/or venular diameters may be clinical predictors of risk for DR as well as for DM.

Strengths of the study include (1) the prospective design with high rates of follow-up for a large cohort of well-characterized African American patients with type 1 DM, (2) use of standardized protocols to document potential confounding variables, (3) masked grading of DR using stereoscopic 7-field retinal photographs, and (4) measurements of the retinal vascular diameters with a previously validated computerized program.

Limitations of the study include the fact that measurement of retinal vessel diameter from color retinal photographs may underestimate the true vascular width because only the red blood cell column is being measured. Conversely, increased retinal pigmentation, as present in African Americans, may lead to an overestimation of the retinal diameter sizes because of reduced contrast between background and retinal vessels.49 Although our results clearly suggest an association between CRVE and progression to either PDR or PDR with HRCs for eyes with less severe baseline DR, a larger sample would be needed to evaluate whether CRVE is a useful indicator in those with more severe baseline DR. Finally, we did not take into account variability of the retinal vessel caliber due to cardiac cycle pulsatility.50

In summary, results of the present study indicate that, in African Americans with type 1 DM, larger CRVE is an independent predictor of progression to PDR with or without HRCs, particularly in eyes with less severe baseline DR, thus providing another early clinical indicator for the progression to the more severe forms of DR. It remains to be seen whether such a measure may be used in the future to monitor treatments for DM and other vascular diseases that specifically target the microvasculature.

Correspondence: Monique S. Roy, MD, Institute of Ophthalmology and Visual Science, UMDNJ-New Jersey Medical School, 90 Bergen St, Room 6164, Newark, NJ 07101 (Roymo@umdnj.edu).

Submitted for Publication: December 2, 2009; final revision received April 19, 2010; accepted April 23, 2010.

Financial Disclosure: None reported.

Funding/Support: This research was supported by grants RO1 EY 09860 and R21 EY 18114-1 from the National Eye Institute and by a Lew Wasserman Merit Award from Research to Prevent Blindness, Inc.

Ballantyne  ALoewenstein  A Diseases of the retina, I: the pathology of diabetic retinopathy. Trans Ophthalmol Soc U K 1943;6395- 115
Bloodworth  J Fine structure of retina in human and canine diabetes mellitus. Kimura  SBloodworth  JCaygill  WVascular Complications of Diabetes Mellitus. St Louis, MO CV Mosby1967;73- 97
Skovborg  FNielsen  AVLauritzen  EHartkopp  O Diameters of the retinal vessels in diabetic and normal subjects. Diabetes 1969;18 (5) 292- 298
PubMed
Early Treatment Diabetic Retinopathy Study Research Group, Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 1991;98 (5) ((suppl)) 786- 806
PubMed Link to Article
Early Treatment Diabetic Retinopathy Study Research Group, Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology 1991;98 (5) ((suppl)) 823- 833
PubMed Link to Article
Parr  JCSpears  GF General caliber of the retinal arteries expressed as the equivalent width of the central retinal artery. Am J Ophthalmol 1974;77 (4) 472- 477
PubMed
Parr  JCSpears  GF Mathematic relationships between the width of a retinal artery and the widths of its branches. Am J Ophthalmol 1974;77 (4) 478- 483
PubMed
Hubbard  LDBrothers  RJKing  WN  et al.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106 (12) 2269- 2280
PubMed Link to Article
Klein  RKlein  BEMoss  SE  et al.  Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. Ophthalmology 2003;110 (11) 2118- 2125
PubMed Link to Article
Klein  RKlein  BEMoss  SEWong  TYSharrett  AR Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology 2006;113 (9) 1488- 1498
PubMed Link to Article
Kifley  AWang  JJCugati  SWong  TYMitchell  P Retinal vascular caliber, diabetes, and retinopathy. Am J Ophthalmol 2007;143 (6) 1024- 1026
PubMed Link to Article
Islam  FNguyen  TWang  J  et al.  Quantitative retinal vascular calibre changes in diabetes and retinopathy: the Singapore Malay eye study. Eye (Lond) 2009;23 (8) 1719- 1724
PubMed Link to Article
Grauslund  JHodgson  LKawasaki  RGreen  ASjolie  AWong  T Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes. Diabetologia 2009;52 (10) 2213- 2217
Link to Article
Klein  RKlein  BEMoss  SE  et al. Wisconsin Epidemiologic Study of Diabetic Retinopathy, The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy, XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 2004;122 (1) 76- 83
PubMed Link to Article
Alibrahim  EDonaghue  KCRogers  S  et al.  Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology 2006;113 (9) 1499- 1503
PubMed Link to Article
Cheung  NRogers  SLDonaghue  KCJenkins  AJTikellis  GWong  TY Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care 2008;31 (9) 1842- 1846
PubMed Link to Article
Roy  MS Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725, I: methodology, population, frequency of retinopathy, and visual impairment. Arch Ophthalmol 2000;118 (1) 97- 104
PubMed Link to Article
Roy  MS Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725, II: risk factors. Arch Ophthalmol 2000;118 (1) 105- 115
PubMed Link to Article
Roy  MSAffouf  M Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 2006;124 (9) 1297- 1306
PubMed Link to Article
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20 (7) 1183- 1197
PubMed
Winter  WEMaclaren  NKRiley  WJClarke  DWKappy  MSSpillar  RP Maturity-onset diabetes of youth in black Americans. N Engl J Med 1987;316 (6) 285- 291
PubMed Link to Article
Diabetic Retinopathy Study Research Group, A modification of the Airlie House classification of diabetic retinopathy: Diabetic Retinopathy Study Report Number 7. Invest Ophthalmol Vis Sci 1981;21210- 226
Canner  PLBorhani  NOOberman  A  et al.  The Hypertension Prevention Trial: assessment of the quality of blood pressure measurements. Am J Epidemiol 1991;134 (4) 379- 392
PubMed
Early Treatment Diabetic Retinopathy Study Research Group, Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103 (12) 1796- 1806
PubMed Link to Article
Knudtson  MDLee  KEHubbard  LDWong  TYKlein  RKlein  BE Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 2003;27 (3) 143- 149
PubMed Link to Article
Atherosclerosis Risk in Communities (ARIC) Study Research Group, ARIC Retinal Photography Protocol, Manual 14A, and ARIC Retinal Reading Center Protocol, Manual 14B.  Chapel Hill ARIC Coordinating Center, Department of Biostatistics (CSCC), University of North Carolina1995;
Couper  DJKlein  RHubbard  LD  et al.  Reliability of retinal photography in the assessment of retinal microvascular characteristics: the Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002;133 (1) 78- 88
PubMed Link to Article
Klein  RKlein  BEMoss  SEDavis  MDDeMets  DL The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IX: four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107 (2) 237- 243
PubMed Link to Article
Goldthorpe  JHope  K The Social Grading of Occupations: A New Approach and Scale.  New York, NY Oxford University Press1974;134- 143
Keen  HChlouverakis  C Metabolic factors in diabetic retinopathy. Graymore  CNBiochemistry of the Retina. New York, NY Academic Press1965;123- 131
Stefansson  ELanders  MB  IIIWolbarsht  ML Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies. Ophthalmic Surg 1983;14 (3) 209- 226
PubMed
de Jong  FJVernooij  MWIkram  MK  et al.  Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters: the Rotterdam Study. Ophthalmology 2008;115 (5) 887- 892
PubMed Link to Article
Izuora  KEChase  HPJackson  WE  et al.  Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care 2005;28 (3) 714- 715
PubMed Link to Article
Joussen  AMPoulaki  VLe  ML  et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18 (12) 1450- 1452
PubMed
Klein  RKlein  BEKnudtson  MDWong  TYTsai  MY Are inflammatory factors related to retinal vessel caliber? the Beaver Dam Eye Study. Arch Ophthalmol 2006;124 (1) 87- 94
PubMed Link to Article
Ikram  MKde Jong  FJVingerling  JR  et al.  Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? the Rotterdam Study. Invest Ophthalmol Vis Sci 2004;45 (7) 2129- 2134
PubMed Link to Article
Wong  TYIslam  FMKlein  R  et al.  Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA). Invest Ophthalmol Vis Sci 2006;47 (6) 2341- 2350
PubMed Link to Article
Mandecka  ADawczynski  JBlum  M  et al.  Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007;30 (12) 3048- 3052
PubMed Link to Article
Nguyen  TTKawasaki  RWang  JJ  et al.  Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 2009;32 (11) 2075- 2080
PubMed Link to Article
Nguyen  TTKawasaki  RKreis  AJ  et al.  Correlation of light-flicker–induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest Ophthalmol Vis Sci 2009;50 (12) 5609- 5613
PubMed Link to Article
Wong  TYKnudtson  MDKlein  RKlein  BEMeuer  SMHubbard  LD Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 2004;111 (6) 1183- 1190
PubMed Link to Article
Wilson  CAStefánsson  EKlombers  LHubbard  LDKaufman  SCFerris  FL  III Optic disk neovascularization and retinal vessel diameter in diabetic retinopathy. Am J Ophthalmol 1988;106 (2) 131- 134
PubMed
Klein  RMoss  SEKlein  BEK Diabetic retinopathy [author reply]. Ophthalmology 2007;114 (11) 2099
Link to Article
Klein  BEKlein  R McBride  PE  et al.  Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 2004;164 (17) 1917- 1924
PubMed Link to Article
Roy  MRendas-Baum  RSkurnick  J Mortality in African-Americans with type 1 diabetes: the New Jersey 725. Diabet Med 2006;23 (6) 698- 706
PubMed Link to Article
Wong  TYKlein  RSharrett  AR  et al. ARIC Investigators, Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 2002;287 (19) 2528- 2533
PubMed Link to Article
Wong  TYShankar  AKlein  RKlein  BEHubbard  LD Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 2005;165 (9) 1060- 1065
PubMed Link to Article
Nguyen  TTWang  JJIslam  FM  et al.  Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes 2008;57 (3) 536- 539
PubMed Link to Article
Rochtchina  EWang  JJTaylor  BWong  TYMitchell  P Ethnic variability in retinal vessel caliber: a potential source of measurement error from ocular pigmentation? the Sydney Childhood Eye Study. Invest Ophthalmol Vis Sci 2008;49 (4) 1362- 1366
PubMed Link to Article
Knudtson  MDKlein  BEKlein  R  et al.  Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle. Br J Ophthalmol 2004;88 (1) 57- 61
PubMed Link to Article

Figures

Tables

Table Graphic Jump LocationTable 1. Baseline Characteristics of African Americans With Type 1 Diabetes Mellitus
Table Graphic Jump LocationTable 2. Relationship Between Mean CRAE and CRVE and Baseline Clinical Characteristics in African Americans With Type 1 Diabetes Mellitus
Table Graphic Jump LocationTable 3. Relationship of CRAE and CRVE to 6-Year Incidence of DR: Univariate Analysis
Table Graphic Jump LocationTable 4. Relationship of Baseline CRVE in Right and Left Eyes to 6-Year Progression to Either PDR or PDR With HRCs: Multivariate GEE Analyses

References

Ballantyne  ALoewenstein  A Diseases of the retina, I: the pathology of diabetic retinopathy. Trans Ophthalmol Soc U K 1943;6395- 115
Bloodworth  J Fine structure of retina in human and canine diabetes mellitus. Kimura  SBloodworth  JCaygill  WVascular Complications of Diabetes Mellitus. St Louis, MO CV Mosby1967;73- 97
Skovborg  FNielsen  AVLauritzen  EHartkopp  O Diameters of the retinal vessels in diabetic and normal subjects. Diabetes 1969;18 (5) 292- 298
PubMed
Early Treatment Diabetic Retinopathy Study Research Group, Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 1991;98 (5) ((suppl)) 786- 806
PubMed Link to Article
Early Treatment Diabetic Retinopathy Study Research Group, Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology 1991;98 (5) ((suppl)) 823- 833
PubMed Link to Article
Parr  JCSpears  GF General caliber of the retinal arteries expressed as the equivalent width of the central retinal artery. Am J Ophthalmol 1974;77 (4) 472- 477
PubMed
Parr  JCSpears  GF Mathematic relationships between the width of a retinal artery and the widths of its branches. Am J Ophthalmol 1974;77 (4) 478- 483
PubMed
Hubbard  LDBrothers  RJKing  WN  et al.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106 (12) 2269- 2280
PubMed Link to Article
Klein  RKlein  BEMoss  SE  et al.  Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. Ophthalmology 2003;110 (11) 2118- 2125
PubMed Link to Article
Klein  RKlein  BEMoss  SEWong  TYSharrett  AR Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology 2006;113 (9) 1488- 1498
PubMed Link to Article
Kifley  AWang  JJCugati  SWong  TYMitchell  P Retinal vascular caliber, diabetes, and retinopathy. Am J Ophthalmol 2007;143 (6) 1024- 1026
PubMed Link to Article
Islam  FNguyen  TWang  J  et al.  Quantitative retinal vascular calibre changes in diabetes and retinopathy: the Singapore Malay eye study. Eye (Lond) 2009;23 (8) 1719- 1724
PubMed Link to Article
Grauslund  JHodgson  LKawasaki  RGreen  ASjolie  AWong  T Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes. Diabetologia 2009;52 (10) 2213- 2217
Link to Article
Klein  RKlein  BEMoss  SE  et al. Wisconsin Epidemiologic Study of Diabetic Retinopathy, The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy, XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 2004;122 (1) 76- 83
PubMed Link to Article
Alibrahim  EDonaghue  KCRogers  S  et al.  Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology 2006;113 (9) 1499- 1503
PubMed Link to Article
Cheung  NRogers  SLDonaghue  KCJenkins  AJTikellis  GWong  TY Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care 2008;31 (9) 1842- 1846
PubMed Link to Article
Roy  MS Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725, I: methodology, population, frequency of retinopathy, and visual impairment. Arch Ophthalmol 2000;118 (1) 97- 104
PubMed Link to Article
Roy  MS Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725, II: risk factors. Arch Ophthalmol 2000;118 (1) 105- 115
PubMed Link to Article
Roy  MSAffouf  M Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 2006;124 (9) 1297- 1306
PubMed Link to Article
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20 (7) 1183- 1197
PubMed
Winter  WEMaclaren  NKRiley  WJClarke  DWKappy  MSSpillar  RP Maturity-onset diabetes of youth in black Americans. N Engl J Med 1987;316 (6) 285- 291
PubMed Link to Article
Diabetic Retinopathy Study Research Group, A modification of the Airlie House classification of diabetic retinopathy: Diabetic Retinopathy Study Report Number 7. Invest Ophthalmol Vis Sci 1981;21210- 226
Canner  PLBorhani  NOOberman  A  et al.  The Hypertension Prevention Trial: assessment of the quality of blood pressure measurements. Am J Epidemiol 1991;134 (4) 379- 392
PubMed
Early Treatment Diabetic Retinopathy Study Research Group, Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103 (12) 1796- 1806
PubMed Link to Article
Knudtson  MDLee  KEHubbard  LDWong  TYKlein  RKlein  BE Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 2003;27 (3) 143- 149
PubMed Link to Article
Atherosclerosis Risk in Communities (ARIC) Study Research Group, ARIC Retinal Photography Protocol, Manual 14A, and ARIC Retinal Reading Center Protocol, Manual 14B.  Chapel Hill ARIC Coordinating Center, Department of Biostatistics (CSCC), University of North Carolina1995;
Couper  DJKlein  RHubbard  LD  et al.  Reliability of retinal photography in the assessment of retinal microvascular characteristics: the Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002;133 (1) 78- 88
PubMed Link to Article
Klein  RKlein  BEMoss  SEDavis  MDDeMets  DL The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IX: four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107 (2) 237- 243
PubMed Link to Article
Goldthorpe  JHope  K The Social Grading of Occupations: A New Approach and Scale.  New York, NY Oxford University Press1974;134- 143
Keen  HChlouverakis  C Metabolic factors in diabetic retinopathy. Graymore  CNBiochemistry of the Retina. New York, NY Academic Press1965;123- 131
Stefansson  ELanders  MB  IIIWolbarsht  ML Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies. Ophthalmic Surg 1983;14 (3) 209- 226
PubMed
de Jong  FJVernooij  MWIkram  MK  et al.  Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters: the Rotterdam Study. Ophthalmology 2008;115 (5) 887- 892
PubMed Link to Article
Izuora  KEChase  HPJackson  WE  et al.  Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care 2005;28 (3) 714- 715
PubMed Link to Article
Joussen  AMPoulaki  VLe  ML  et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18 (12) 1450- 1452
PubMed
Klein  RKlein  BEKnudtson  MDWong  TYTsai  MY Are inflammatory factors related to retinal vessel caliber? the Beaver Dam Eye Study. Arch Ophthalmol 2006;124 (1) 87- 94
PubMed Link to Article
Ikram  MKde Jong  FJVingerling  JR  et al.  Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? the Rotterdam Study. Invest Ophthalmol Vis Sci 2004;45 (7) 2129- 2134
PubMed Link to Article
Wong  TYIslam  FMKlein  R  et al.  Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA). Invest Ophthalmol Vis Sci 2006;47 (6) 2341- 2350
PubMed Link to Article
Mandecka  ADawczynski  JBlum  M  et al.  Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007;30 (12) 3048- 3052
PubMed Link to Article
Nguyen  TTKawasaki  RWang  JJ  et al.  Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 2009;32 (11) 2075- 2080
PubMed Link to Article
Nguyen  TTKawasaki  RKreis  AJ  et al.  Correlation of light-flicker–induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest Ophthalmol Vis Sci 2009;50 (12) 5609- 5613
PubMed Link to Article
Wong  TYKnudtson  MDKlein  RKlein  BEMeuer  SMHubbard  LD Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 2004;111 (6) 1183- 1190
PubMed Link to Article
Wilson  CAStefánsson  EKlombers  LHubbard  LDKaufman  SCFerris  FL  III Optic disk neovascularization and retinal vessel diameter in diabetic retinopathy. Am J Ophthalmol 1988;106 (2) 131- 134
PubMed
Klein  RMoss  SEKlein  BEK Diabetic retinopathy [author reply]. Ophthalmology 2007;114 (11) 2099
Link to Article
Klein  BEKlein  R McBride  PE  et al.  Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 2004;164 (17) 1917- 1924
PubMed Link to Article
Roy  MRendas-Baum  RSkurnick  J Mortality in African-Americans with type 1 diabetes: the New Jersey 725. Diabet Med 2006;23 (6) 698- 706
PubMed Link to Article
Wong  TYKlein  RSharrett  AR  et al. ARIC Investigators, Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 2002;287 (19) 2528- 2533
PubMed Link to Article
Wong  TYShankar  AKlein  RKlein  BEHubbard  LD Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 2005;165 (9) 1060- 1065
PubMed Link to Article
Nguyen  TTWang  JJIslam  FM  et al.  Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes 2008;57 (3) 536- 539
PubMed Link to Article
Rochtchina  EWang  JJTaylor  BWong  TYMitchell  P Ethnic variability in retinal vessel caliber: a potential source of measurement error from ocular pigmentation? the Sydney Childhood Eye Study. Invest Ophthalmol Vis Sci 2008;49 (4) 1362- 1366
PubMed Link to Article
Knudtson  MDKlein  BEKlein  R  et al.  Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle. Br J Ophthalmol 2004;88 (1) 57- 61
PubMed Link to Article

Correspondence

CME


You need to register in order to view this quiz.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,384 Views
30 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
An Illustration of Bias and Random Error

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
An Illustration of Bias and Random Error